8 Results for "

Anti-IgE

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Anti-IgE" in MCE Product Catalog:

Cat. No.: HY-P99313
CAS No.: 1228538-47-3
Synonyms: Anti-Human IGHE Recombinant Antibody

Target:  

Apoptosis

Research Areas:  

Inflammation/Immunology

Quilizumab (Anti-Human IGHE Recombinant Antibody) is a humanized IgG1κ monoclonal antibody targeting immunoglobulin epsilon (also konwn as: IGHE, IgE). Quilizumab targets the M1-prime fragment of membrane-expressed IGHE/IgE, leading to IGHE/IgE switching and memory B cell depletion. Quilizumab has potential in asthma research .
loading...
    loading...
Cat. No.: HY-103183
CAS No.: 53296-10-9
Purity:  98%
Synonyms: 2-Phenylaminoadenosine
CV1808 (2-Phenylaminoadenosine) is a non-selective A2 adenosine receptor (A2 AR) agonist with Kis of 76 and 1450 nM for A2A and A3 adenosine receptor subtypes, respectively .
loading...
    loading...
Cat. No.: HY-P99319
CAS No.: 380610-22-0
Synonyms: TNX 901; Anti-Human IgE Fc Recombinant Antibody

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Talizumab (TNX 901) is an anti-IgE humanized IgG1 monoclonal antibody .
loading...
    loading...
Cat. No.: HY-19108
CAS No.: 104795-68-8
Target:  

Calcium Channel Actin

Research Areas:  

Inflammation/Immunology Cancer

CI-959 is an orally active cell activation inhibitor. CI-959 selectively suppresses inflammatory cell activation post-receptor signaling via inhibiting calcium influx and weak calmodulin antagonism, without targeting PLC, PKC or NADPH oxidase. CI-959 blocks lung allergic mediator release, anti-IgE bronchial contraction, neutrophil function, T-cell proliferation and DC marker expression while sparing monocytes. CI-959 provides gastric cytoprotection by inhibiting leukocyte adhesion and suppresses tumor motility through F-actin reduction. CI-959 can be used for research on allergies, inflammation, autoimmune diseases, gastric injury, and tumor metastasis .
loading...
    loading...
Cat. No.: HY-103183R
CAS No.: 53296-10-9
Synonyms: 2-Phenylaminoadenosine (Standard)
CV1808 (Standard) is the analytical standard of CV1808. This product is intended for research and analytical applications. CV1808?(2-Phenylaminoadenosine) is a non-selective A2?adenosine receptor (A2 AR) agonist with Kis of 76 and 1450 nM for A2A and A3 adenosine receptor subtypes, respectively .
loading...
    loading...
Cat. No.: HY-113886
CAS No.: 104795-66-6
Target:  

Calcium Channel Actin

Research Areas:  

Inflammation/Immunology Cancer

CI-959 free acid is an orally active cell activation inhibitor. CI-959 free acid selectively suppresses inflammatory cell activation post-receptor signaling via inhibiting calcium influx and weak calmodulin antagonism, without targeting PLC, PKC or NADPH oxidase. CI-959 free acid blocks lung allergic mediator release, anti-IgE bronchial contraction, neutrophil function, T-cell proliferation and DC marker expression while sparing monocytes. CI-959 free acid provides gastric cytoprotection by inhibiting leukocyte adhesion and suppresses tumor motility through F-actin reduction. CI-959 free acid can be used for research on allergies, inflammation, autoimmune diseases, gastric injury, and tumor metastasis .
loading...
    loading...
Cat. No.: HY-N11725
CAS No.: 128129-56-6
Phlorofucofuroeckol A is a FcεRI inhibitor with low cytotoxicity toward basophilic leukemia cells. Phlorofucofuroeckol A suppresses binding activity between IgE and FcεRI receptor. Phlorofucofuroeckol A inhibits histamine release from basophilic leukemia cells stimulated by IgE/anti-IgE or calcium ionophore A23187 (HY-N6687). Phlorofucofuroeckol A inhibits β-hexosaminidase release from basophilic leukemia cells stimulated by IgE/DNP-BSA. Phlorofucofuroeckol A can be used for the research of allergy disease .
loading...
    loading...
Cat. No.: HY-182414
CAS No.: 81907-78-0
Target:  

Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

NCO-650 free base is an antiallergic agent that acts by inhibiting tryptase, a key trypsin-like protease in mast cells. NCO-650 free base inhibits mast cell histamine release, increases intracellular cAMP levels in mast cells, suppresses bronchoconstriction, and prevents decreases in perfusion pressure and systemic blood pressure. NCO-650 free base is applicable to the research of allergic diseases and bronchial asthma .
loading...
    loading...